India’s health ministry has banned around 350 fixed dose combination (FDC) drugs that were widely available in the market till now. These medicines include FDCs based on codine, used in popular cough syrups like Phensedyl and Corex.
The government has decided to prohibit manufacturing and sale of these medicines because they were found to be “irrational” without any therapeutic efficacy and use.
Officials told Times of India that in some cases, there were concerns about misuse of such medicines considered unsafe for mass consumption.
According to health experts, many unapproved formulations and FDCs are sold in India. Most of these medicines are in the analgesics, anti-depressant and psychotic condition segment. Industry estimates suggest the move is likely to impact pharmaceutical sales to the tune of around Rs 1,500 crore.
No comments:
Post a Comment